McKesson, CD&R to take infusion therapy provider Option Care private in $5.8 billion deal

Drug distributor McKesson and private equity firm Clayton Dubilier & Rice on Tuesday agreed to take infusion therapy ​provider Option Care Health private in a deal worth about $5.8 billion including ‌...

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。